GlaxoSmithKline Pakistan Market Cap

GlaxoSmithKline Pakistan has a market cap or net worth of 117.55 billion as of May 15, 2025. Its market cap has increased by 275.27% in one year.

Market Cap

117.55B

Enterprise Value

111.73B

Revenue

61.15B

Ranking

n/a

PE Ratio

14.52

Stock Price

369.12

Market Cap Chart

Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 117.55B, an increase of 3,017.41%. That is a compound annual growth rate of 11.88%.

Market Cap History

Date	Market Cap	% Change
May 14, 2025	117.55B	-7.00%
Dec 31, 2024	126.40B	378.26%
Dec 29, 2023	26.43B	-5.45%
Dec 30, 2022	27.95B	-35.70%
Dec 31, 2021	43.47B	-28.84%
Dec 31, 2020	61.09B	19.47%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Abbott Laboratories (Pakistan)	90.64B
AGP Limited	51.73B
Highnoon Laboratories	48.47B
The Searle Company	38.39B
Shifa International Hospitals	27.73B
Citi Pharma	17.87B
Ferozsons Laboratories	12.53B
Otsuka Pakistan	2.34B

Market Cap Rankings